We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -1.35% | 11.00 | 10.50 | 10.80 | 11.30 | 10.95 | 11.30 | 169,640 | 16:29:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -7.75 | 64.22M |
TIDMETX
RNS Number : 8457P
e-Therapeutics plc
05 September 2017
E-THERAPEUTICS PLC
("e-therapeutics" or the "Company")
Notification of Half Year Results Date
Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six months ended 31 July 2017 on Tuesday, 26 September 2017.
-Ends-
For more information, please contact:
e-therapeutics plc Tel: +44 (0) 1993 Ray Barlow, Chief Executive 883 125 Officer www.etherapeutics.co.uk Steve Medlicott, Finance Director Numis Securities Limited Tel: +44 (0) 207 Michael Meade/Freddie Barnfield 260 1000 (Corporate Finance) www.numis.com James Black (Corporate Broking) Instinctif Partners Tel: +44 (0) 207 Melanie Toyne Sewell/Alex 457 2020 Shaw Email: e-therapeutics@instinctif.com
About e-therapeutics plc
We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.
Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.
e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORVELBBDKFZBBB
(END) Dow Jones Newswires
September 05, 2017 04:41 ET (08:41 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions